Neuroone Medical Technologies (NMTC) Invested Capital (2010 - 2026)

Neuroone Medical Technologies has disclosed Invested Capital across 17 years of filings, most recently posting $5.1 million for Q1 2026.

• Quarterly Invested Capital rose 350.97% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (up 350.97% YoY) and the FY2025 annual result came in at $7.1 million, up 760.39% from the prior year.
• Invested Capital slipped to $5.1 million in Q1 2026, from $6.4 million in the prior quarter.
• Across five years, Invested Capital topped out at $13.1 million in Q1 2022 and bottomed at $822013.0 in Q3 2024.
• The 5-year median for Invested Capital is $5.5 million (2023), against an average of $5.9 million.
• Year-over-year, Invested Capital slumped 87.11% in 2024 and soared 760.39% in 2025.
• Neuroone Medical Technologies' Invested Capital stood at $8.2 million in 2022, then plunged by 45.93% to $4.4 million in 2023, then tumbled by 33.56% to $2.9 million in 2024, then jumped by 118.1% to $6.4 million in 2025, then fell by 20.69% to $5.1 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $5.1 million, $6.4 million, and $7.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.